Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 9Unknown 3Terminated 2

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 43Thoracic 31Lymphoid 5Other solid neoplasm 3Gastrointestinal 3CNS 3Sarcoma 2Tumor-Agnostic 1Gynecologic 1Genitourinary 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1Mesothelioma, Malignant 1Advanced Solid Tumors 1

Interventions

Injections 17Cisplatin 15Carboplatin 15Oxaliplatin 11Gemcitabine 11pembrolizumab 8Capecitabine 8toripalimab 7Paclitaxel 7Etoposide 7Cyclophosphamide 7Pemetrexed 6Irinotecan 6Drug Therapy 6spartalizumab 5fludarabine 5camrelizumab 5Vincristine 5Radiotherapy 5Leucovorin 5tislelizumab 4apatinib 4anlotinib 4Interleukin-2 4Immune Checkpoint Inhibitors 4Granulocyte-Macrophage Colony-Stimulating Factor 4Fluorouracil 4Docetaxel 4Bevacizumab 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Vinorelbine × Other solid neoplasm × Clear all
NCT00006088 2013-09-20

Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Unknown
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00030459 2013-08-07

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

National Cancer Institute (NCI)

Phase 2 Unknown
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01220284 2010-10-13

Satraplatin and Vinorelbine in Advanced Solid Tumors

Southern Europe New Drug Organization

Phase 1 Unknown
27 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡